Research progress on Chikungunya virus and its risk of transfusion transmission
10.13303/j.cjbt.issn.1004-549x.2025.12.005
- VernacularTitle:基孔肯雅病毒研究进展及输血传播风险
- Author:
Rui WANG
1
;
Bo WANG
2
;
Xiaozhen GUAN
1
;
Yang YU
1
Author Information
1. Department of Transfusion Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China
2. The Southern Medical Brach of PLA Genetal Hospital, Beijing 100071, China
- Publication Type:Journal Article
- Keywords:
Chikungunya virus;
arthritis;
infection;
transfusion-transmitted infection
- From:
Chinese Journal of Blood Transfusion
2025;38(12):1678-1686
- CountryChina
- Language:Chinese
-
Abstract:
Chikungunya virus (CHIKV) is a mosquito-borne pathogen, which mainly causes severe joint pain and can be life-threatening in severe cases. In recent years, with the continuous outbreaks and prevalence of CHIKV worldwide, there has been increasing concerns about the extent of the risk for transfusion transmission. This article reviews the epidemiological history of CHIKV, its molecular biology, infection and pathogenesis, diagnosis and treatment, vaccine development, transfusion transmission risk and blood screening strategies. It aims to provide a reference for future epidemic control and prevention and for reducing the risk of transfusion transmission.
